Why I gave taking antidepressants a second chance with NMOSD
Although taking antidepressants years ago didn't help her mood, columnist Jennifer V. recently decided to give the treatment another try.| Neuromyelitis News
Although taking antidepressants years ago didn't help her mood, columnist Jennifer V. recently decided to give the treatment another try.| Neuromyelitis News
Ultomiris safely and effectively reduces relapse risk in complex NMOSD cases and may be safe in combination with rituximab for short periods.| Neuromyelitis News
Using noninvasive eye scans may help clinicians determine if patients have NMOSD or MS, particularly in early disease stages, a study found.| Neuromyelitis News
A review of nearly 100 articles found that muscle problems are relatively common in NMOSD, affecting more than one-third of patients.| Neuromyelitis News
The gut hormone GLP-1 may drive brain inflammation in NMOSD patients, leading to nausea, vomiting, or hiccups, called area postrema syndrome.| Neuromyelitis News
Bilateral vision loss, the use of a walking aid, fatigue, and depression predict employment loss after a NMOSD diagnosis, a study shows.| Neuromyelitis News
Ultomiris, an approved infusion therapy for neuromyelitis optica spectrum disorder, is closer to being eligible for reimbursement in Canada.| Neuromyelitis News
Enspryng was safe and effective for nearly 9 years in people with NMOSD who have antibodies against AQP4, according to data from two trials.| Neuromyelitis News
Over a recent concert weekend, columnist Jennifer V. and a U.S. friend bonded over the similarities between their cases of NMOSD and MOGAD.| Neuromyelitis News
Nearly all adults with neuromyelitis optica spectrum disorder NMOSD) experience headaches, especially migraines, a study in Iran shows.| Neuromyelitis News
As an immune-compromised NMOSD patient, columnist Jennifer V. wishes others would remember the lessons of the pandemic.| Neuromyelitis News
The platelet-to-lymphocyte ratio may be used as a biomarker of disability severity in people with NMOSD, a study found.| Neuromyelitis News
Columnist Jennifer V. explains what "bed rotting" is and how it can be useful for NMOSD patients who need rest and recovery to avoid flares.| Neuromyelitis News
NMOSD patients who are positive for the anti-AQP4 antibodies were more likely to have other autoimmune diseases, a study in Argentina shows.| Neuromyelitis News
A new predictive model to identify neuromyelitis optica spectrum disorder patients at a higher risk of relapse was found accurate in a study.| Neuromyelitis News
A Phase 1 clinical study tested the therapy in 15 patients positive for antibodies against AQP4, those most commonly associated with NMOSD.| Neuromyelitis News
Living with NMOSD and its resulting disability can make it hard to find and keep employment, a new U.S. study highlights.| Neuromyelitis News
MS is an autoimmune disease that affects the central nervous system. Learn more about MS types, causes, symptoms, diagnosis, and treatment.| Multiple Sclerosis News Today
